Serena Jones, a director and 10% owner of Goosehead Insurance, Inc. (NASDAQ:GSHD), filed a Form 4 on August 21, 2026, reporting a series of LLC Unit conversions and Class A Common Stock sales that took place on August 19 and August 20, 2026.
Astha Malik, Chief Business Officer of Braze, Inc. (NASDAQ:BRZE), filed a Form 4 on August 21, 2026, reporting the sale of a total of 15,724 shares of Class A Common Stock on August 19, 2026, pursuant to a Rule 10b5-1 trading plan.
Cassandra Knight, Chief Legal and Policy Officer of Zillow Group, Inc., filed a Form 4 on August 21, 2026, reporting equity awards granted on August 20, 2026, consisting of restricted stock units and stock options covering Class C Capital Stock.
Jay David Youngblood, Senior Vice President and Chief Digital Officer of Avnet Inc, filed a Form 4 on August 21, 2026, disclosing the acquisition of 7,090 shares of common stock on August 20, 2026.
Kathy J. Warden, Chair, CEO and President of Northrop Grumman Corp /DE/ (NYSE:NOC), filed a Form 4 on August 21, 2026, disclosing the acquisition of 35,910 Market Stock Units on August 19, 2026.
Phillips 66 filed a current report on August 21, 2026, disclosing that its wholly owned subsidiary, Phillips 66 Company, entered into the Fifth Amendment to its accounts receivable securitization program on August 20, 2026.
Northrop Grumman Corporation filed an 8-K with the Securities and Exchange Commission on August 21, 2026, disclosing that its Board of Directors approved a one-time performance-based equity grant to Chair, Chief Executive Officer and President Kathy J. Warden on August 19, 2026.
Dream Finders Homes, Inc. filed a Form 8-K on August 21, 2026, reporting that its Board of Directors approved amendments to the company's 2021 Equity Incentive Plan on August 20, 2026, including a revised compensation limit for certain non-employee directors and two administrative changes.
The Boeing Company filed a current report on August 21, 2026, disclosing the appointment of Ryan L. Shedd as Senior Vice President and Controller, effective following the filing of Boeing's annual report for the year ended December 31, 2026.
Starling Oncology, Inc. filed a Current Report on Form 8-K on August 21, 2026, disclosing that its wholly owned subsidiary entered into a revolving credit agreement with Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL, providing access to up to $25 million in revolving …